Miromatrix Medical Inc Quick Ratio (MIRO) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Miromatrix Medical inc   (NASDAQ: MIRO)

Miromatrix Medical Inc 's Quick Ratio

MIRO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 3.23 a new company low.

Within Biotechnology & Pharmaceuticals industry 103 other companies have achieved higher Quick Ratio than Miromatrix Medical Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 562 to 978.

Explain Quick Ratio?
How much Cash & cash equivalents MIRO´s has?
What are MIRO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MIRO Quick Ratio (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3
Y / Y Current Liabilities Change 22.37 % 48.14 % 109.65 % 8.37 % 14.05 %
Y / Y Cash & cash equivalent Change -49.08 % -75.87 % -42.7 % -52.29 % -49.2 %
Quick Ratio MRQ 3.23 5.25 7.7 5.09 7.77
MIRO's Total Ranking # 978 # 562 # 468 # 697 # 444
Seq. Current Liabilities Change 27.74 % 16.91 % -32.78 % 21.89 % 54.64 %
Seq. Cash & cash equivalent Change -21.27 % -20.33 % 1.62 % -20.11 % -62.7 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 104
Healthcare Sector # 486
Overall Market # 978


Quick Ratio Statistics
High Average Low
27.06 9.67 3.23
(Jun 30 2021)   (Sep 30 2023)




Financial Statements
Miromatrix Medical Inc 's Current Liabilities $ 5 Millions Visit MIRO's Balance sheet
Miromatrix Medical Inc 's Cash & cash equivalent $ 16 Millions Visit MIRO's Balance sheet
Source of MIRO's Sales Visit MIRO's Sales by Geography


Cumulative Miromatrix Medical Inc 's Quick Ratio

MIRO's Quick Ratio for the trailling 12 Months

MIRO Quick Ratio

 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 33.45 % 31.5 % 22.91 % -26.12 % -3.67 %
Y / Y Cash & cash equivalent TTM Growth -59.14 % -57.92 % -26.19 % 0.06 % 60.52 %
Quick Ratio TTM 5.1 6.34 11.16 14.07 16.64
Total Ranking TTM # 3570 # 3408 # 2982 # 587 # 0
Seq. Current Liabilities TTM Growth 5.6 % 8.45 % 13.16 % 2.98 % 4.05 %
Seq. Cash & cash equivalent TTM Growth -15.07 % -38.44 % -10.26 % -12.93 % -12.51 %

Quick ratio ranking by company, industry and sector >> Back to MIRO Financial Strength Comparisons >> Go to Compare MIRO Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2023 to $4.97 millions, cumulative Quick Ratio decreased to 5.1 below the Miromatrix Medical Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 171 other companies have achieved higher Quick Ratio than Miromatrix Medical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3408 to 3570.

Explain Quick Ratio?
How much Cash & cash equivalents MIRO´s has?
What are MIRO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 172
Healthcare Sector # 1030
Within the Market # 3570


trailing twelve months Quick Ratio Statistics
High Average Low
10.99 7.6 5.1
(Dec 31 2022)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Jasper Therapeutics Inc   8.72 $ 103.867  Millions$ 11.906  Millions
Springworks Therapeutics Inc   8.40 $ 422.419  Millions$ 50.283  Millions
Turnstone Biologics Corp   8.35 $ 109.221  Millions$ 13.081  Millions
Century Therapeutics inc   8.29 $ 169.505  Millions$ 20.435  Millions
Autolus Therapeutics Plc  7.98 $ 256.415  Millions$ 32.149  Millions
Atyr Pharma Inc   7.93 $ 102.131  Millions$ 12.881  Millions
Monte Rosa Therapeutics Inc   7.89 $ 178.477  Millions$ 22.609  Millions
Tscan Therapeutics Inc   7.49 $ 215.423  Millions$ 28.775  Millions
Tracon Pharmaceuticals Inc   7.19 $ 7.763  Millions$ 1.080  Millions
Immunovant Inc   6.81 $ 269.928  Millions$ 39.645  Millions
Palisade Bio Inc   6.74 $ 15.312  Millions$ 2.273  Millions
Passage Bio Inc   6.70 $ 132.780  Millions$ 19.811  Millions
Humacyte Inc   6.61 $ 99.986  Millions$ 15.137  Millions
Surrozen Inc   6.51 $ 43.432  Millions$ 6.672  Millions
Kalaris Therapeutics Inc   6.45 $ 213.318  Millions$ 33.066  Millions
Tenaya Therapeutics Inc   6.28 $ 121.753  Millions$ 19.377  Millions
Ginkgo Bioworks Holdings Inc   6.23 $ 1,049.244  Millions$ 168.462  Millions
Inhibikase Therapeutics Inc   6.14 $ 16.832  Millions$ 2.742  Millions
Zura Bio Limited  6.11 $ 103.859  Millions$ 17.012  Millions
Leonabio Inc   6.04 $ 172.948  Millions$ 28.622  Millions
Editas Medicine Inc   5.97 $ 349.617  Millions$ 58.603  Millions
Finch Therapeutics Group Inc   5.90 $ 28.779  Millions$ 4.879  Millions
X4 Pharmaceuticals Inc  5.83 $ 141.683  Millions$ 24.316  Millions
Biontech Se  5.72 $ 13,263.936  Millions$ 2,318.960  Millions
Prime Medicine Inc   5.70 $ 160.500  Millions$ 28.147  Millions
Fresh Tracks Therapeutics Inc   5.70 $ 12.020  Millions$ 2.108  Millions
Dyadic International Inc   5.61 $ 8.176  Millions$ 1.457  Millions
Curis Inc   5.50 $ 68.498  Millions$ 12.446  Millions
Aim Immunotech Inc   4.97 $ 22.431  Millions$ 4.509  Millions
Kodiak Sciences Inc   4.88 $ 345.668  Millions$ 70.774  Millions

Date modified: 2026-09-26T07:40:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.